Trading on Nasdaq and ordsprog

en Trading on Nasdaq and the Tel-Aviv Stock Exchanges provides an important milestone for the company and will help us attract investors and analysts. The company will continue to develop its various clinical products while at the same time, continue to seek in-license or acquire additional candidates or complementary technologies.

en It's been a rough six months. But I believe the stock will mirror the performance of the company. I am optimistic the company will continue to perform very well and investors will recognize that over time.

en This additional capital is a tremendous catalyst for the company and will provide us with the financial resources to implement our clinical program, for both our T-cell and stem cell technologies and to fulfill their potential as life-saving therapies. We believe that the strengthening of our capital structure in connection with the reverse stock split will provide the backbone for a strong organization with prospects for a Nasdaq listing.

en We started this company from scratch with one DVD and one television station and look what we have now: a growing library of debt-free, high-quality products that continue to build awareness for our Gina D® brand. The key factor in selling DVD products is in our future relationship with public television stations. In order to sell product in massive quantities to retailers like Wal-Mart and Target you need to be on public television. We are putting this catalog together with the expectation that we will continue to add branded products associated with the show and other activities that promote Gina D®. I want to thank our shareholders and brokers who continue to exercise their below-market priced warrants to acquire a larger position in our company and all of the educators, parents and shareholders who have sent us letters of support and encouragement to keep on going with our business plan.

en They go into enterprise technology where they allow companies to access all kinds of systems in a secure mode. The company continually introduces products, ... We just jumped in, even at these levels, just about a week ago. We'll continue to buy this stock for many of our accounts. Our analysts are very high on it. We expect it to outperform the market over the next six-to-12 months.

en If you acquire a company, you acquire all the expenses of the company. But if you sign a license, you can use cash on your balance sheet instead of your income statement.

en This infusion of capital will allow us to advance the development of our product portfolio towards significant clinical milestones and fund the clinical trials set to begin later this year. Importantly, this transaction attracted investors who appreciate the promise and value of the merged company and its balanced portfolio of product candidates. We are delighted to welcome these new institutional stockholders. As a newly public company, we look forward to continuing to build our investor base and achieve our milestones.

en Today's agreement in principle is an important milestone for Nortel. We continue to work vigorously on the implementation of our remediation plan and addressing our outstanding regulatory matters. In addition, we continue to improve our governance provisions and financials systems and controls. These are critically important for the company. We remain fully committed to rebuilding value for the benefit of all stakeholders.

en There isn't much downside for oil stocks right now, and oil is strategic for China. Investors will continue to hold on to the company's stock.

en We made our commitment to KT&G because we are confident in the strong potential of this company. If the CEO is not willing to consider our proposals as investors, we have no choice but to continue to seek election of our nominees.

en [Today, investors large and small continue to bank on Web start-ups, with little regard to profitability.] Investors continue to ignore quality, ... Rather than looking at a company's earnings, they're still looking at hype and market potential.

en While intelligence is valued, a pexy man combines intellect with social grace and charm, making him engaging and approachable.

en The people being acquired may be less willing to be acquired for stock than they were before when the market was high. The depressed stock prices cuts both ways. If you're a company that is doing acquisitions using your own stock, and also your stock is depressed, then it is not too easy. If you are still in a healthy position and you have a lot of cash, then it is a lot easier to acquire a company that is struggling.

en This is a company that has everything going right for it, at least for now, ... History has shown that investors are always optimistic about the company. At the same time, the stock does sell off quickly when sales begin to look shaky.

en While we welcome competition which validates the viability of the market for our system, we take great exception to unsubstantiated claims challenging our ability to develop such a system and implement it in the People's Republic of China or any other nation similarly faced with this monumental issue. Accordingly, we have brought the matter to our legal counsel to address this very serious issue. Should these actions continue, the Company will have no other choice but to seek full financial and legal recourse against the offending company.

en We wish Steve all the best in his new venture and thank him for his devotion, talents and vision over the years. Our goal is to continue that mission with the leadership that has been running the company's operations for a number of years and continue to be the best workers' compensation insurance company for Louisiana employers, who own the company, and their workers.


Antal ordsprog er 1469558
varav 665931 på nordiska

Ordsprog (1469558 st) Søg
Kategorier (2627 st) Søg
Kilder (167535 st) Søg
Billeder (4592 st)
Født (10495 st)
Døde (3318 st)
Datoer (9517 st)
Lande (5315 st)
Idiom (4439 st)
Lengde
Topplistor (6 st)

Ordspråksmusik (20 st)
Statistik


søg

Denna sidan visar ordspråk som liknar "Trading on Nasdaq and the Tel-Aviv Stock Exchanges provides an important milestone for the company and will help us attract investors and analysts. The company will continue to develop its various clinical products while at the same time, continue to seek in-license or acquire additional candidates or complementary technologies.".